Simmondsin was modiˆed with acarviosine-glucose using the transglycosylation activity of Thermus maltogenic amylase to synthesize a novel compound with both antiobesity and hypoglycemic activity. The LC W MS and 13 C NMR analyses conˆrmed that the structure of the major transglycosylation product was acarviosinesimmondsin (Acv-simmondsin), in which acarviosine was attached to the glucose moiety of simmondsin by an a-(1,6)-glycosidic linkage. It was found that Acvsimmondsin was a potent competitive inhibitor of aglucosidase with the K i value of 0.69 mM and a mixed type inhibitor of a-amylase with the K i and K I of 20.78 mM and 26.31 mM, respectively. The administration of Acv-simmondsin (0.1 g W 100 g diet W day) to mice for 5 days signiˆcantly reduced food intake by 35%, compared to 25% with simmondsin in control obese mice. Acv-simmondsin (50 mg W kg BW) suppressed the postprandial blood glucose response to sucrose (1 g W kg BW) by 74%, compared to 71% with acarbose, in normal rats.
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Key words: Thermus maltogenic amylase; transglycosylation; acarviosine-simmondsin; acarbose; food intake Maltogenic amylases and related enzymes from Bacillus and Thermus species can hydrolyze various substrates having a-(1,4)-and W or a-(1,6)-glycosidic linkages as found in starch, pullulan, cyclomaltodextrin (CD), and acarbose, with diŠerent substrate speciˆcities. [1] [2] [3] In addition they have strong transglycosylation activity, forming a-(1,3), a- (1, 4) , and a-(1,6)-glycosidic linkage in the presence of various acceptor molecules. [4] [5] [6] [7] Likewise, the maltogenic amylase can react with theˆrst a-(1,4)-glycosidic linkage of acarbose, a potent a-glucosidase and a-amylase inhibitor, to produce acarviosine-glucose and glucose, and then transfer the acarviosine-glucose to an acceptor molecule, simmondsin, resulting in pseudotrisaccharide (PTS; acarviosine-glucose)-simmondsin. 8) M äuller et al. reported that the acarbose molecule could be hydrolyzed by a-amylase, but the reaction product, acarviosine-glucose, was not degraded by aamylase or b-amylase. 9, 10) It was also found that an acarviosyl transferase (ATase) cloned from Actinoplanes sp. catalyzed the transfer of the acarviosyl moiety of acarbose to malto-oligosaccharides.
11)
Remarkably, we have found that maltogenic amylase is also capable of cleaving theˆrst a-(1,4)-glycosidic linkage of acarviosine-glucose to produce acarviosine and glucose. This unique catalytic activity is a novel property that has not been observed in other amylolytic enzymes and makes it possible to modify various acceptor molecules with acarviosine by the transglycosylation reaction of maltogenic amylase.
Agents having both antiobesity and hypoglycemic activity might be useful in the control and treatment of obesity and diabetes at the same time. In the previous work, PTS-simmondsin was synthesized from the transglycosylation reaction with simmondsin and acarbose, which lowers body weight gain by food intake inhibition and postprandial hyperglycemia by the inhibition of digestive enzymes, such as aamylase and a-glucosidase, respectively. 8, 12) It was demonstrated that PTS-simmondsin not only inhibits the body weight gain but also lowers postprandial hyperglycemia in diabetic and obese animal models. However, the eŠective dose of hypoglycemic activity was much lower than that of antiobesity activity. In this study, a novel compound was synthesized by the transglycosylation reaction of Thermus maltogenic amylase (ThMA) with acarviosine-glucose and simmondsin for the purpose of reducing the discrepancy in the eŠective doses of antiobesity and hypoglycemic activity of PTS-simmondsin. A new acarviosine transfer product was produced and puried, and its structure was analyzed by LC-MS and 13 C NMR. In addition, the inhibition kinetics of the puriˆed compound against rat intestinal a-glucosidase and porcine pancreatic a-amylase were studied followed by an in vivo experiment looking for antiobesity and hypoglycemic eŠects.
Materials and Methods
Materials. Acarbose was a generous gift from Bayer Korea Ltd. (Seoul, Korea). Simmondsin was puriˆed by the USDA (Peoria, IL, USA) as previously reported. 13 5) Cultivation of the recombinant E. coli and puriˆcation of the enzyme were described previously.
5) The hydrolysis activity of ThMA was assayed using 0.5z (w W v) b-cyclodextrin ( b-CD) as a substrate in 50 mM sodium acetate buŠer (pH 6.0) at 609 C. The reducing sugar produced was identiˆed by 3,5-dinitrosalicylic acid (DNS) method.
14)
Preparation of acarviosine-glucose. For the preparation of acarviosine-glucose (AG), 1z (w W v) acarbose in 50 mM sodium acetate buŠer, pH 6.0, was incubated with 5 units of ThMA per mg of acarbose for 12 h at 609 C. After the reaction was completed, the reaction mixture was put onto an activated charcoal column (3.6×25 cm) equilibrated with distilled water. The sample was washed with distilled water at a ‰ow rate of 2 ml W min, and acarviosine-glucose was eluted with 40z (w W v) ethanol. Theˆnal product was analyzed by TLC after removing ethanol by a rotary vacuum evaporator (Eyela, Tokyo, Japan).
Hydrolysis and transglycosylation of AG by ThMA. Acarviosine-glucose was reacted with ThMA in order to investigate the hydrolysis pattern of the ThMA. The reaction mixture consisted of 1z (w W v) AG in 50 mM sodium acetate buŠer (pH 6.0) and 50 U of ThMA W mg substrate. After incubation at 559 C for 24 h, the reaction was stopped by boiling for 5 min. Then, the reaction products were analyzed by TLC and HPIC (High performance ion chromatography). The transglycosylation reaction of AG by ThMA was done in the presence of simmondsin as an acceptor. ThMA was added to a mixture of 5z (w W v) AG and 10z (w W v) simmondsin in sodium acetate buŠer (50 mM, pH 6.0) and the reaction was done at 559 C for 72 h. A silica gel K6F TLC plate (Whatman, Kent, UK) with a solvent system of isopropyl alcohol W ethyl acetate W water (v W v W v W ＝ 3:1:0.5) was used for the TLC analysis of the transglycosylation product. Simmondsin transfer products were puriˆed by cation exchange chromatography with an SP-Sepharose column (2.6× 30 cm, Sigma, St. Louis, MO, USA) and followed by gelˆltration chromatography with Bio-Gel P2 column (1.6×90 cm, Bio-Rad, Hercules, CA, USA). The fractions of transfer products were pooled and further puriˆed by preparative TLC. The amount of transfer products was approximately measured by UV spectrophotometry (Ultrospec III, Pharmacia LKB, Uppsala, Sweden) at 215 nm.
HPIC analysis was done after centrifugation of the reaction mixture at 12,000×g for 10 min andˆltra-tion through a 0.45-mm membraneˆlter kit. Twenty ml of sample was put onto a CarboPac PA1 column (0.4×25 cm, Dionex, Sunnyvale, CA, USA) equipped with an electrochemical detector (ED40, Dionex, Sunnyvale, CA). The sample was eluted with a linear gradient from 100z buŠer A (150 mM NaOH in water) to 30z buŠer B (600 mM sodium acetate in buŠer A) over 30 min. The ‰ow rate of mobile phase was maintained at 1.0 ml W min.
Mass Spectrometry. JEOL JMS-LC mate (Tokyo, Japan) was used to measure the molecular weight of the major transfer product with ESI interface. LC-MS measurements were done by operating the massselective detector in the positive ion mode. Five ml of the sample at the concentration of 100 mg W ml was directly injected into the instrument.
Nuclear Magnetic Resonance Spectroscopy. The 13 C NMR spectra of the major transfer product was recorded with a JNM LA-FT-NMR spectrometer (400 MHz, JEOL, Tokyo, Japan). The sample was dissolved in DMSO-d6 at 24.99 C with tetramethyl silane (TMS) as the internal reference.
Enzyme assay for inhibition kinetics. The activity of a-glucosidase was continuously measured for the inhibition kinetic study using glucose-oxidase W peroxidase method with slight modiˆcation.
12) The enzyme reaction mixture was composed of 0.6 ml of a maltose solution in 50 mM phosphate buŠer (pH 7.0), 50 ml of reagent A (13,000 units glucose oxidase, 40 mg peroxidase, and 3,500 units mutarotase in 50 ml of 50 mM phosphate buŠer, pH 7.0), and 50 ml of reagent B (50 mg 4-aminoantipyrine and 50 ml phenol in 50 ml of 50 mM phosphate buŠer, pH 7.0). Inhibitor (0.1 ml) was preincubated with the enzyme solution at 379 C for 10 min. The enzyme solution incubated with the inhibitor was then added to the reaction mixture and the change of absorbance was continuously measured at 505 nm for 15 min using a Ultrospec III spectrophotometer (Pharmacia, Uppsala, Sweden) thermostatted at 379 C. The amount of D-glucose formed was measured using a glucose standard curve.
Alpha-amylase activity was measured using the copper bicinchoninate reducing-value method with a microsample plate reader. 15) A solution of soluble starch was prepared in 50 mM sodium phosphate buŠer containing 6 mM NaCl (pH 6.9). First, 0.8 ml of a soluble starch solution was incubated with or without inhibitors at 379 C for 5 min. Inhibitor was incubated with the enzyme solution at 379 C for 10 min. Then the reaction was started by adding 0.2 ml of this enzyme solution. Samples were taken at appropriate times (20, 50, and 80 s) and mixed immediately with 0.2 ml copper-bicinchoninate reagent. Samples were heated at 809 C in a water bath for 35 min, cooled, and then added to the wells of a microsample plate. Various concentrations of maltose solutions were used as standards. The absorbances were measured using a microsample plate reader (EL340 Biokinetics Reader, Bio-Tech Instruments, Inc., Winooski, VT, USA). The kinetic parameters were calculated using Lineweaver-Burk and Dixon plots as well as DNRPEASY software for general enzyme inhibition, developed by Duggleby and Leonard. 16) Inhibitory action on food intake in vivo. Eightweek-old male lean (ob W + or ? W +) and ob W ob (C57BL W 6J-Lep; genetically obese and diabetic) mice (Jackson Laboratory, Bar Harbor, ME, USA) were housed individually in a temperature-controlled room at 249 C with a 12-12 h light-dark cycle, lights on at 7:00 AM. They were given Acv-simmondsin (0.1 g W 100 g diet) as a dietary admixture for 5 days. Simmondsin was also tested as a positive control. Food intake rate and body weight were measured at 09:00 AM daily. The statistical signiˆcance was evaluated by Duncan's multiple range test (SAS software, SAS Institute, Cary, NC, USA).
Inhibitory action on postprandial hyperglycemia in vivo. After being starved for 24 h, 5-week-old male Sprague Dawley rats (Daehan Biolink Co., Umsung, Korea) were given Acv-simmondsin at a dose of 10 or 50 mg W kg in combination with sucrose solution (1 g W kg of body wt) by gastral intubation. Acarbose was also tested as a positive control. Blood samples from the ophthalmic venous plexus were taken at 0, 1, and 3 h after sucrose administration. The glucose level in the plasma was measured by a glucose assay kit (Sigma Chemical Co., St. Louis, MO). The area under the glycemic response curve (AUC) was calculated by the diŠerence between the intubated glucose and the remaining glucose value in plasma. Total AUC was obtained by the trapezoidal rule. AUC represents the sum of the trapezoidal areas and is expressed as mg×h W dl. The statistical signiˆcance was evaluated by Duncan's test (a＝0.05) (SAS software, SAS Institute, Cary, NC).
Results and Discussion
Hydrolysis of AG by ThMA ThMA had the hydrolyzing activity on acarbose and AG. As shown in Fig. 1 , ThMA completely hydrolyzed AG to acarviosine and glucose. It was known that the hydrolyzed product, acarviosine, is very unstable and rearranges itself to form a tricyclic compound. 9, 17) To make the compound visible on the TLC plate, we used alkaline silver nitrate dipping reagent, 18) as it was not detectable on TLC plates by routine carbohydrate-staining methods such as N-(1-napthyl)-ethylenediamine reagent and the sulfuric acid procedure. Acarbose is known to be degraded to AG and glucose by some a-amylase or maltogenic amylases, and to acarviosine and maltose by b-amylase. 6, 9) To our knowledge, an enzyme that hydrolyzes AG has not been reported previously although the transferring activity of ATase has been reported recently.
11) However, our result clearly showed that AG could be hydrolyzed by maltogenic amylase into acarviosine and glucose. This unique property of ThMA of hydrolyzing AG in combination with transferring activity enables transglycosylation of acarviosine onto simmondsin.
Transglycosylation reaction of AG with simmondsin by ThMA
When the transglycosylation reaction of AG with simmondsin by ThMA was done, two transfer products appeared, as shown in Fig. 2 . These compounds were puriˆed by SP-sepharose cation exchange chromatography, followed by Bio-Gel P2 gel ltration chromatography and preparative TLC. The puriˆed compounds were analyzed by LC W MS to measure the molecular masses. The mass spectrum of the major transfer product (spot 2 in Fig. 2) is shown in Fig. 3 + ), which corresponded to the calculated molecular masses of proton and sodium ion adducts of acarviosine-simmondsin (Acv-simmondsin; 678 Da), respectively. This result indicated that the transglycosylation product by ThMA was Acv-simmondsin. The minor transfer product (spot 1 in Fig. 2 ) also had a molecular mass of 678 Da (data not shown), suggesting that these compounds might be the same molecule, Acv-simmondsin, with diŠer-ent glycosidic linkages.
Structure of the glycosidic linkage of transfer product
To identify the glycosidic linkage between acarviosine and simmondsin in the major transfer product, 13 C NMR analysis was done. The chemical shift of Acv-simmondsin was compared with those of simmondsin and acarbose as listed in Table 1 . There is a large chemical shift from 60.96 to 65.62 ppm of C-6 in the D-glucose unit in simmondsin, indicating the acarviosine group was linked to C-6 of the D-glucose moiety of simmondsin. From these results, the major transfer product was deˆned as acarviosine-a-(1,6)-simmondsin. The TLC chromatogram (Fig. 2, lane b) gave distinct separation of two compounds. The minor transfer product migrated faster than the major product on TLC but slower in HPIC. From the analysis of TLC and HPIC, it can be postulated that the minor transfer product is probably an isomer of the main Acv-simmondsin compound, and possibly acarviosine-a-(1,3)-simmondsin, in which acarviosine connected to simmondsin by an a-(1,3)-glycosidic linkage. This is based on the fact that the component, AG with the a-(1,3)-linkage, generally migrates faster than the product with a-(1,6)-linkages on TLC and slower in HPIC. 6) From the structural determinations, a reaction scheme for acarviosine transfer from AG by ThMA is proposed (Fig. 4) . Acarbose is hydrolyzed by ThMA to AG and glucose. The resulting AG is further hydrolyzed to acarviosine and glucose. When simmondsin is added as an acceptor, ThMA transfers acarviosine to simmondsin, primarily forming a-(1,6)-linkage between acarviosine and simmondsin. In contrast, the compounds, modiˆed by ATase, diŠer in the position of the glycosidic linkages.
11) The hydroxyl groups at positions 2, 3 and 4 of D-glucose can be modiˆed with an acarviosyl moiety by ATase, while positions 3, 4 and 6 of D-glucose are available for maltogenic amylase. 6) Inhibition of rat intestinal a-glucosidase and porcine pancreatic a-amylase
The inhibition activity of Acv-simmondsin was studied against rat intestinal a-glucosidase and porcine pancreatic a-amylase. The Lineweaver-Burk and Dixon plots indicate the type of inhibition of Acvsimmondsin against rat intestinal a-glucosidase was competitive inhibition whereas that against porcine pancreatic a-amylase was a mixed type inhibition. The inhibition constants, K i and K I , and the potency of the inhibitor are given in Table 2 . Comparing the inhibition constants of three inhibitors that contain the acarviosine moiety, namely acarbose, PTS-simmondsin, and Acv-simmondsin, Acv-simmondsin has an inhibitor potency comparable to that of PTSsimmondsin for a-glucosidase. The inhibition of rat intestinal a-glucosidase by Acv-simmondsin was competitive with a Ki value of 0.69 mM, while the values of acarbose and PTS-simmondsin were 0.06 mM and 0.31 mM, respectively. The inhibitor potency of Acv-simmondsin was one-tenth of that of acarbose. Acv-simmondsin inhibited porcine pancreatic aamylase with a Ki of 20.78 mM and KI of 26.31 mM. PTS-simmondsin has the highest inhibitor potency with 60 times that of acarbose and it is consistent with our previous results on other AG-containing transfer products. 12) The inhibitor potency of Acvsimmondsin was decreased to 0.05, which is much less than that of PTS-simmondsin. Acv-simmondsin clearly inhibits a-glucosidase from the rat intestine eŠectively, but it reduces the activity of porcine pancreatic a-amylase much less. It is necessary that aglucosidase inhibitors like acarbose have to be administered in doses that allow all carbohydrates to be digested and adsorbed completely within the small intestine. If not, the undigested carbohydrates will enter the colon and, as a consequence of bacterial fermentation, give rise to side eŠects such as ‰atu-lence. 19) Therefore, the relative e‹cacy of inhibition of a-glucosidase and a-amylase is important for the regulation of carbohydrate absorption by enzyme inhibition. Considering the relative inhibition activity against starch-digesting enzymes, Acv-simmondsin might be the most eŠective inhibitor among three inhibitors containing an acarviosine moiety for an antiobesity treatment.
Inhibitory action on food intake and postprandial hyperglycemia in vivo
Acv-simmondsin reduced body weight gain in both lean and obese mice through altering food intake (Table 3) . In lean mice, Acv-simmondsin and simmondsin decreased food intake by 32z and 17z, respectively. In body weight gain, Acv-simmondsin reduced it by 63z, but simmondsin-treated animals showed no gain. Likewise, in obese mice, Acv-simmondsin and simmondsin diminished food intake by 35z and 25z in that order. In obese mice, Acvsimmondsin and simmondsin result in no body weight gain or decreased body weight, "0.01 or "0.24 g W mouse W day, correspondingly. Acv-simmondsin was calculated from the daily food intake to be fed at a dose of 131 mg W kg BW W day in lean mice, and 86.1 mg W kg BW W day in obese mice. Those amounts of intakes were close to the eŠective dose of hypoglycemic activity (50 mg W kg BW).
When PTS-simmondsin was orally administered at a dose of 100 mg W kg BW twice a day (200 mg W kg BW W day) for 6 days, it did not reduce food intake, but suppressed body weight gain by 78z, whereas simmondsin restricted it by 80z in lean mice in our previous work. 8) In ob W ob mice, PTS-simmondsin decreased food intake by 19z comparable to simmondsin (25z), and suppressed body weight gain by 74z, also similar to simmondsin (62z). At a lower intake than that of PTS-simmondsin, Acv-simmondsin more e‹ciently inhibited food intake and body weight gain in both lean and ob W ob mice with respect to PTS-simmondsin. The routes of administration may aŠect the inhibition of food intake and body weight gain. In our work, addition to the food was more e‹cient than intragastric intubation, in agreement with previous work. 20) Acv-simmondsin at a dose of 10 mg W kg BW had no eŠect on the elevation of the blood glucose concentration after sucrose administration, while acarbose showed a signiˆcant eŠect in our experiments (data not shown). The high dose (50 mg W kg BW) of Acv-simmondsin suppressed the elevation of the blood glucose concentration by 86z after 1 hr and 88 z after 2 hr, and AUC by 74z, while acarbose did by 73z after 1 h and by 77z after 2 hr and AUC by 71z (Table 4 ). In our previous work, PTS-simmondsin (10 mg W kg BW) decreased the postprandial hyperglycemia after starch administration (2 g W kg BW) in Zucker fa W fa rats at a similar degree as acarbose. 8) Therefore, Acv-simmondsin is weaker on hypoglycemic activity than PTS-simmondsin.
In conclusion, we have shown that the transfer of an acarviosine group from AG to simmondsin by the action of ThMA results in Acv-simmondsin with very interesting properties including inhibition of food intake and a-glucosidase activity, with which a-amylase inhibition activity was minimized using adequate adjustment of the dosage.
